News
|
Markets
|
watchlist
|
Menu
JAMI RUBIN
Related Articles
Pfizer’s Two New Top Pills Selling Slower Than Expected
6 days ago
Teva Faces Israel Backlash on Jobs Amid Cost-Cut Plan
3 months ago
Pfizer Breakup Talk Stoked by Discount to Drug Stocks
4 months ago
Pfizer Will Consider Split of Drug Units, CEO Read Says
5 months ago
Bristol-Myers Tops Profit Estimates on Tax Benefit
5 months ago
Pfizer’s Possible Unit Shuffle Triggers Breakup Concern
5 months ago
Teva Focuses on Central Nervous System, Respiratory Drugs
6 months ago
Teva Focuses on Central Nervous System, Respiratory Drugs
6 months ago
Lilly Last Hope for Alzheimer’s as Pfizer, J&J Bow Out
10 months ago
Lilly Profit Beats Analyst Estimates as Cymbalta Sales Rise
11 months ago
Show More News
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=199532570&utmp=%2Ftopics%2Fjami-rubin%2F&utmhn=10.248.67.13&utmac=UA-11413116-12&utmhid=164177875)